Investor AB Class A
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Ulf Christian Cederholm
- Full Time Employees
- 19,351
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Arsenalsgatan 8C Stockholm AB Sweden 103 32
- IPO Date
- Mar 31, 1905
- Website
- investorab.com
- Similar Companies
- Business
- Investor AB (publ) Investor AB (publ) is a Swedish investment holding company founded in 1916 and headquartered in Stockholm that serves as the principal investment vehicle for the Wallenberg family, focusing on long-term ownership in high-quality global companies across multiple sectors including industrials, healthcare, telecommunications, and financial services. The company operates through three primary business areas: Listed Companies, with significant holdings in entities such as ABB, AstraZeneca, Atlas Copco, Ericsson, Epiroc, Husqvarna, Nasdaq, Saab, SEB, and Sobi; Patricia Industries, which manages wholly-owned operating companies like Mölnlycke Health Care (wound care products), Permobil (wheelchairs and mobility solutions), Laborie (urology and gastroenterology equipment), Advanced Instruments (osmolality testing instruments), Piab (automation gripping systems), Sarnova (emergency healthcare products), BraunAbility (automotive mobility), Vectura (real estate), and 3 Scandinavia (mobile services); and Investments in EQT, encompassing stakes in EQT AB and its funds for private equity opportunities. Investor AB maintains a global footprint with operations spanning Sweden, Europe, the United States, and other regions, targeting mature businesses with strong market positions through controlling or influential minority stakes, board representation, and active ownership strategies. Recent developments include Patricia Industries subsidiary Advanced Instruments completing its USD 2.2 billion acquisition of Nova Biomedical in 2025, with the combined entity now operating as Nova Biomedical; additional investments such as SEK 1.8 billion in EQT X's Fortnox co-investment, purchases of shares in Atlas Copco and Ericsson totaling SEK 1.1 billion, and an agreement to divest 5 million SEB shares, alongside a reported adjusted net asset value of SEK 1,028 billion as of September 30, 2025.
Company News
Marvell: Investor Day Resets The AI Growth Story
Investor AB (publ) (IVSBF) Q2 2026 Earnings Call Transcript
Stellantis Presents FaSTLAne 2030 Financial Framework & Targets at Investor Day 2026
Stellantis to Present New Strategic Plan Today at Investor Day 2026
Investor AB (publ) (OTCMKTS:IVSBF) Shares Up 0.3% – Time to Buy?
Stellantis to Present Strategic Plan at May 21 Investor Day
Investor AB (publ) (IVSBF) Q4 2025 Earnings Call Transcript
RioCan Real Estate Investment Trust Announces Investor Day and Third Quarter 2025 Earnings Release, Conference Call and Webcast
Investor AB: Better NAV Discounts Are Out There
'Top priority is to grow portfolio of companies,' Investor AB CEO says
Investor AB (publ) (IVSXF) Q2 2025 Earnings Call Transcript
Kartoon Studios to Report Q4 2024 Results Pre-Market on March 31
Pilgrim's Announces $1.5 Billion Special Dividend and Long-term Capital Allocation Strategy
Investor AB: No NAV Angle Even When Ignoring State Of Private Markets
Investor AB (publ) (IVSXF) Q4 2024 Earnings Call Transcript
SEC Charges Multiple Individuals and Entities in Relationship Investment Scams
Greenlight Re Announces Second Quarter 2024 Financial Results
Investor AB (publ) (IVSXF) Q2 2024 Earnings Call Transcript
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors with Losses to Contact the Firm
JPMorgan Chase Raises FY24 Net Interest Income Guidance Amid Economic Caution